Gynecologic and obstetric investigation
-
Gynecol. Obstet. Invest. · Jan 2012
Interview with Prof. Dr. Marleen Temmerman, new director of the WHO Department of Reproductive Health and Research, assuming office on October 15, 2012. Interview by Thomas M. D'Hooghe.
In this interview with the editor of Gynecologic and Obstetric Investigation, Prof. Dr. Marleen Temmerman, the new director of the WHO Department of Reproductive Health and Research (October 15, 2012), presents her vision on the role of WHO collaborating centers; the relationship between scientific research, guideline development, implementation, and policy; the need to prioritize family planning, and the need to improve perinatal and maternal health but also to address other global reproductive health problems like infertility, pelvic pain, dysfunctional bleeding, and sexually transmitted diseases, which deserve more attention from the WHO. She also addresses the challenge to increase funding for WHO sexual and reproductive health research.
-
Gynecol. Obstet. Invest. · Jan 2012
Editorial Historical ArticleHuman reproduction program: the first partnership for health and development at the WHO.
-
Gynecol. Obstet. Invest. · Jan 2011
Randomized Controlled Trial Comparative StudyA randomized comparison of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting.
Nausea and vomiting are the most common causes of postoperative complications, and they are seen most often after operations performed using general anesthesia and sedation. We designed this study to compare the effects of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic operations. ⋯ We conclude that metoclopramide is not effective in preventing postoperative nausea and vomiting after gynecologic operations. Droperidol, tropisetron, and ondansetron are effective; however, the sedating effects of droperidol and tropisetron should be considered.
-
To examine the association between interpregnancy body mass index (BMI) change and stillbirth. ⋯ BMI change appears to play an important role in subsequent stillbirth risk.